Karl Kölbeck
- Pulmonary and Respiratory Medicine top 5%
- Oncology top 5%
- Molecular Biology
- Cancer Research
- Radiology, Nuclear Medicine and Imaging
- Co-authors
- Janessa LaskinTony MokVera HirshShun LüLuis Paz‐AresMichael BoyerKenneth J. O’ByrneAngela Märten
- Topics
- Lung Cancer Treatments and Mutations (12 papers)Lung Cancer Diagnosis and Treatment (6 papers)Lung Cancer Research Studies (4 papers)
- Partner nations
- SwedenUnited KingdomUnited States
In The Last Decade
Karl Kölbeck
22 papers receiving 720 citations
Hit Papers
Peers
Comparison fields: 5 of 62
- Pulmonary and Respiratory Medicine 598
- Oncology 483
- Molecular Biology 155
- Cancer Research 97
- Radiology, Nuclear Medicine and Imaging 50
Countries citing papers authored by Karl Kölbeck
This map shows the geographic impact of Karl Kölbeck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karl Kölbeck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karl Kölbeck more than expected).
Fields of papers citing papers by Karl Kölbeck
This network shows the impact of papers produced by Karl Kölbeck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karl Kölbeck. The network helps show where Karl Kölbeck may publish in the future.
Co-authorship network of co-authors of Karl Kölbeck
This figure shows the co-authorship network connecting the top 25 collaborators of Karl Kölbeck. A scholar is included among the top collaborators of Karl Kölbeck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karl Kölbeck. Karl Kölbeck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 2 | |
| 3 | 19 | |
| 4 | 31 | |
| 5 | 6 | |
| 6 | 1 | |
| 7 | Afatinib versus gefitinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: overall survival data from the phase IIb LUX-Lung 7 trialbreakdown → | 398 |
| 8 | 1 | |
| 9 | 22 | |
| 10 | 0 | |
| 11 | 9 | |
| 12 | 1 | |
| 13 | 11 | |
| 14 | [Pulmonary tularemia: rare disease that can be interpreted as lung cancer. Serology provides the correct diagnosis, as shown by case reports]. | 2 |
| 15 | 1 | |
| 16 | 146 | |
| 17 | 14 | |
| 18 | 18 | |
| 19 | 21 | |
| 20 | 5 |
About Karl Kölbeck
Karl Kölbeck is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging, having authored 23 papers that have together received 736 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (12 papers), Lung Cancer Diagnosis and Treatment (6 papers) and Lung Cancer Research Studies (4 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (598 citations), Oncology (483 citations) and Cancer Research (97 citations). Karl Kölbeck has collaborated with scholars based in Sweden, United Kingdom and United States. Frequent co-authors include Janessa Laskin, Tony Mok, Vera Hirsh, Shun Lü, Luis Paz‐Ares, Michael Boyer, Kenneth J. O’Byrne, Angela Märten, James Chih‐Hsin Yang and Gunnar Hillerdal. Their work appears in journals such as Journal of Clinical Oncology, Scientific Reports and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.